Altimmune (ALT) EBT Margin Growth (3y) (2013 - 2025)
Altimmune (ALT) EBT Margin Growth (3y) (2013 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBT Margin Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
49,756.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
441.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Altimmune |
336.67 Mn |
336.67 Mn |
- |
- |
| Date | Value |
|---|
| Dec 31, 2025 |
2.62 Mn |
| Sep 30, 2025 |
80.54 Mn |
| Jun 30, 2025 |
-19.13 Mn |
| Mar 31, 2025 |
-34.41 Mn |
| Dec 31, 2024 |
-46.34 Mn |
| Sep 30, 2024 |
-43.57 Mn |
| Jun 30, 2024 |
-47.47 Mn |
| Mar 31, 2024 |
-48.61 Mn |
| Dec 31, 2023 |
-2.36 Mn |
| Sep 30, 2023 |
-508,897.00 |
| Jun 30, 2023 |
-26.92 Mn |
| Mar 31, 2023 |
-9.54 Mn |
| Dec 31, 2022 |
19.72 Mn |
| Sep 30, 2022 |
-118.39 Mn |
| Jun 30, 2022 |
-25.14 Mn |
| Mar 31, 2022 |
-6.10 Mn |
| Dec 31, 2021 |
89,188.00 |
| Sep 30, 2021 |
-2.11 Mn |
| Jun 30, 2021 |
-1.77 Mn |
| Mar 31, 2021 |
-161,898.00 |
